Bobko M - Search Results

1

5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a potent and selective inhibitor of human vascular beta-type platelet-derived growth factor receptor tyrosine kinase.

Dolle RE, Dunn JA, Bobko M, Singh B, Kuster JE, Baizman E, Harris AL, Sawutz DG, Miller D, Wang S, et al. Dolle RE, et al. Among authors: bobko m. J Med Chem. 1994 Aug 19;37(17):2627-9. doi: 10.1021/jm00043a002. J Med Chem. 1994. PMID: 8064792 No abstract available.

2

Synthesis, characterization, and conformational analysis of the D/L-Tic7 stereoisomers of the bradykinin receptor antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin.

Sawutz DG, Salvino JM, Seoane PR, Douty BD, Houck WT, Bobko MA, Doleman MS, Dolle RE, Wolfe HR. Sawutz DG, et al. Among authors: bobko ma. Biochemistry. 1994 Mar 8;33(9):2373-9. doi: 10.1021/bi00175a004. Biochemistry. 1994. PMID: 8117696

3

Structure determination, pharmacological evaluation, and structure-activity studies of a new cyclic peptide substance P antagonist containing the new amino acid 3-prenyl-beta-hydroxytyrosine, isolated from Aspergillus flavipes.

Barrow CJ, Doleman MS, Bobko MA, Cooper R. Barrow CJ, et al. Among authors: bobko ma. J Med Chem. 1994 Feb 4;37(3):356-63. doi: 10.1021/jm00029a007. J Med Chem. 1994. PMID: 7508512

4

Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors.

Medina JR, Becker CJ, Blackledge CW, Duquenne C, Feng Y, Grant SW, Heerding D, Li WH, Miller WH, Romeril SP, Scherzer D, Shu A, Bobko MA, Chadderton AR, Dumble M, Gardiner CM, Gilbert S, Liu Q, Rabindran SK, Sudakin V, Xiang H, Brady PG, Campobasso N, Ward P, Axten JM. Medina JR, et al. Among authors: bobko ma. J Med Chem. 2011 Mar 24;54(6):1871-95. doi: 10.1021/jm101527u. Epub 2011 Feb 22. J Med Chem. 2011. PMID: 21341675

5

Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK).

Cywin CL, Zhao BP, McNeil DW, Hrapchak M, Prokopowicz AS, Goldberg DR, Morwick TM, Gao A, Jakes S, Kashem M, Magolda RL, Soll RM, Player MR, Bobko MA, Rinker J, DesJarlais RL, Winters MP. Cywin CL, et al. Among authors: bobko ma. Bioorg Med Chem Lett. 2003 Apr 17;13(8):1415-8. doi: 10.1016/s0960-894x(03)00163-x. Bioorg Med Chem Lett. 2003. PMID: 12668002

6

Analogues of human parathyroid hormone (1-31)NH(2): further evaluation of the effect of conformational constraint on biological activity.

Condon SM, Darnbrough S, Burns CJ, Bobko MA, Morize I, Uhl J, Jariwala NU, Burke K, Labaudiniere RF. Condon SM, et al. Among authors: bobko ma. Bioorg Med Chem. 2002 Mar;10(3):731-6. doi: 10.1016/s0968-0896(01)00335-2. Bioorg Med Chem. 2002. PMID: 11814862

7

Discovery of a new class of p38 kinase inhibitors.

Dumas J, Sibley R, Riedl B, Monahan MK, Lee W, Lowinger TB, Redman AM, Johnson JS, Kingery-Wood J, Scott WJ, Smith RA, Bobko M, Schoenleber R, Ranges GE, Housley TJ, Bhargava A, Wilhelm SM, Shrikhande A. Dumas J, et al. Among authors: bobko m. Bioorg Med Chem Lett. 2000 Sep 18;10(18):2047-50. doi: 10.1016/s0960-894x(00)00270-5. Bioorg Med Chem Lett. 2000. PMID: 10999467

8

Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesis.

Smith RA, Hertzog DL, Osterhout MH, Ladouceur GH, Korpusik M, Bobko MA, Jones JH, Phelan K, Romero RH, Hundertmark T, MacDougall ML, Livingston JN, Schoen WR. Smith RA, et al. Among authors: bobko ma. Bioorg Med Chem Lett. 2002 May 6;12(9):1303-6. doi: 10.1016/s0960-894x(02)00143-9. Bioorg Med Chem Lett. 2002. PMID: 11965376

9

Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach.

Smith RA, Barbosa J, Blum CL, Bobko MA, Caringal YV, Dally R, Johnson JS, Katz ME, Kennure N, Kingery-Wood J, Lee W, Lowinger TB, Lyons J, Marsh V, Rogers DH, Swartz S, Walling T, Wild H. Smith RA, et al. Among authors: bobko ma. Bioorg Med Chem Lett. 2001 Oct 22;11(20):2775-8. doi: 10.1016/s0960-894x(01)00571-6. Bioorg Med Chem Lett. 2001. PMID: 11591521

10

Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.

Axten JM, Medina JR, Blackledge CW, Duquenne C, Grant SW, Bobko MA, Peng T, Miller WH, Pinckney T, Gallagher TF, Kulkarni S, Lewandowski T, Van Aller GS, Zonis R, Ward P, Campobasso N. Axten JM, et al. Among authors: bobko ma. Bioorg Med Chem Lett. 2012 Jun 15;22(12):4028-32. doi: 10.1016/j.bmcl.2012.04.086. Epub 2012 Apr 25. Bioorg Med Chem Lett. 2012. PMID: 22579486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page